These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1066352)

  • 1. Disapperance of osteogenic sarcoma after irradiation: immunologic observations.
    Urtasun RC; Connachie PR
    J Can Assoc Radiol; 1976 Jun; 27(2):80-3. PubMed ID: 1066352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteogenic sarcoma. Immunologic parameters before and during immunotherapy with tumor-specific transfer factor.
    Levin AS; Byers VS; Fudenberg HH; Wybran J; Hackett AJ; Johnston JO; Spitler LE
    J Clin Invest; 1975 Mar; 55(3):487-99. PubMed ID: 1078826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immunity in human osteogenic sarcoma.
    Gangal SG; Agashe SS; Nair PN; Rao RS
    Indian J Cancer; 1973 Sep; 10(3):295-301. PubMed ID: 4522531
    [No Abstract]   [Full Text] [Related]  

  • 4. [Humoral immunity in human sarcomas].
    Sergeev SI; Bergol'ts VM; Kovalev BN; Timofeevskaia EA
    Vopr Onkol; 1976; 22(8):17-21. PubMed ID: 1069401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell mediated immunity in human osteogenic sarcoma.
    Agashe SS; Nair PN; Rao RS; Gangal SG
    Indian J Cancer; 1975 Mar; 12(1):61-6. PubMed ID: 1058832
    [No Abstract]   [Full Text] [Related]  

  • 6. Cell mediated immunity in osteogenic sarcoma. Role of the regional lymph nodes.
    Rao RS; Agashe SS; Nair PN; Gangal SG
    Indian J Cancer; 1975 Mar; 12(1):56-60. PubMed ID: 1058831
    [No Abstract]   [Full Text] [Related]  

  • 7. Longitudinal studies of cellular immunity of patients with osteogenic sarcoma during chemoimmunotherapy.
    Sears HF; Simon R; Rosenberg SA
    Cancer Treat Rep; 1980; 64(4-5):589-97. PubMed ID: 6933004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte and serum-mediated immunity in murine osteosarcoma.
    Miller CW; Fisher SJ
    J Bone Joint Surg Am; 1977 Oct; 59(7):981-3. PubMed ID: 269112
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation of in vitro immune response with clinical course of malignant neoplasia in dogs.
    Brodey RS; Fidler IJ; Bech-Nielsen S
    Am J Vet Res; 1975 Jan; 36(1):75-80. PubMed ID: 1054221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfer factor therapy in osteogenic sarcoma.
    Levin AS; Byers VS; Fudenberg HH; Wybran J; Hackett AJ; Johnston JO
    Trans Assoc Am Physicians; 1974; 87():153-8. PubMed ID: 4549141
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumor-specific cell-mediated immunity in household contacts of cancer patients.
    Byers VS; Levin AS; Hackett AJ; Fudenberg HH
    J Clin Invest; 1975 Mar; 55(3):500-13. PubMed ID: 1078827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre- and postoperative studies of in vitro cell-mediated reactivity in canine osteosarcoma.
    Bech-Nielsen S; Reif JS; Brodey RS
    Am J Vet Res; 1978 Jan; 39(1):87-93. PubMed ID: 272858
    [No Abstract]   [Full Text] [Related]  

  • 13. [Neo-adjuvant therapy in childhood osteogenic sarcoma: a pilot study of selective postoperative chemotherapy based on response to preoperative high-dose methotrexate].
    Sasaki K; Matsuoka H; Murakami T; Fujimoto T; Takayanagi F; Sawai K; Niwa J; Hara K
    Gan To Kagaku Ryoho; 1986 May; 13(5):1837-45. PubMed ID: 3486634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of virus-induced rat osteosarcoma.
    Urovitz EP; Czitrom AA; Langer F; Gross AE; Pritzker PH
    J Bone Joint Surg Am; 1976 Apr; 58(3):308-11. PubMed ID: 1063128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The host immune response in human osteosarcoma.
    McMaster JH; Ferguson RJ; Weinert CR
    Clin Orthop Relat Res; 1975 Sep; (111):76-82. PubMed ID: 1057466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant presence of tumor-specific cytotoxic and inhibitor lymphocytes in patients with osteogenic sarcoma.
    Yu A; Watts H; Jaffe N; Parkman R
    N Engl J Med; 1977 Jul; 297(3):121-7. PubMed ID: 325412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary function tests during adjuvant lung irradiation for osteogenic sarcoma.
    Carcelen A; Zaharia M; Caceres E; Moran M; Tejada F
    Cancer Treat Rep; 1980; 64(4-5):701-03. PubMed ID: 6933006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro studies of cell mediated immunity to human sarcomas.
    Rella W; Kotz R; Vetterlein M
    Osterr Z Onkol; 1974; (3-4):89-96. PubMed ID: 4143396
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dose fractionation in photon and neutron therapy in the combined treatment of osteogenic sarcoma].
    Musabaeva LI; Lantsman IuV; Lisin VA; Modiaev VP; Maritskiĭ SV; Vaks KP
    Med Radiol (Mosk); 1990 Apr; 35(4):27-32. PubMed ID: 2336007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Electrophoretic mobility of T and B lymphocytes in bone tumor patients].
    Xie GL
    Zhonghua Zhong Liu Za Zhi; 1986 Jan; 8(1):39-41. PubMed ID: 3015533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.